Zurcher Kantonalbank Zurich Cantonalbank Has $1.38 Million Stock Holdings in Balchem Co. (NASDAQ:BCPC)

Zurcher Kantonalbank Zurich Cantonalbank grew its position in Balchem Co. (NASDAQ:BCPC - Free Report) by 21.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,471 shares of the basic materials company's stock after purchasing an additional 1,510 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Balchem were worth $1,381,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of BCPC. Westside Investment Management Inc. bought a new position in shares of Balchem in the third quarter valued at approximately $27,000. R Squared Ltd acquired a new stake in shares of Balchem in the fourth quarter worth $29,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Balchem in the third quarter worth $35,000. Venturi Wealth Management LLC acquired a new stake in shares of Balchem in the fourth quarter worth $95,000. Finally, Smartleaf Asset Management LLC grew its stake in shares of Balchem by 230.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock worth $106,000 after acquiring an additional 450 shares during the last quarter. Institutional investors own 87.91% of the company's stock.

Balchem Stock Performance

BCPC traded down $2.23 during trading on Friday, reaching $161.17. 758,211 shares of the company's stock were exchanged, compared to its average volume of 113,342. Balchem Co. has a fifty-two week low of $137.69 and a fifty-two week high of $186.03. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The business has a 50 day moving average price of $164.71 and a 200 day moving average price of $169.43. The company has a market capitalization of $5.24 billion, a P/E ratio of 41.01, a PEG ratio of 4.41 and a beta of 0.63.

Remove Ads

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The business had revenue of $240.00 million for the quarter, compared to analyst estimates of $239.96 million. As a group, analysts predict that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on BCPC shares. HC Wainwright restated a "buy" rating and issued a $190.00 price objective on shares of Balchem in a research note on Monday, February 24th. StockNews.com downgraded shares of Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Finally, Sidoti upgraded shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.